Effects of disease on expression and regulation of CYPs.
Farrell
G
G
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics / Q000378:metabolism; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics* / Q000378:metabolism*; D004195:Disease Models, Animal; D005355:Fibrosis / Q000378:metabolism / Q000473:pathology; D005786:Gene Expression Regulation; D006801:Humans; D007239:Infections / Q000378:metabolism / Q000503:physiopathology; D007249:Inflammation / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008107:Liver Diseases / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D008115:Liver Regeneration; D010089:Oxidoreductases, N-Demethylating / Q000235:genetics / Q000378:metabolism; D013959:Thyroid Diseases / Q000378:metabolism
C400322:cytochrome P-450 CYP2C subfamily; D003577:Cytochrome P-450 Enzyme System; D019392:Cytochrome P-450 CYP2E1; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D010089:Oxidoreductases, N-Demethylating